Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $7.86B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Anika Therapeutics USD 379M 166M Jun/2025
Arrowhead Research USD 8.04B 973M Feb/2026
Heron Therapeutics USD 145M 6M Sep/2023
Incyte USD 22.7B 3.31B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Nektar Therapeutics USD 113M 4M Sep/2023
Novartis USD 265.66B 9.48B Sep/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
TG Therapeutics USD 5.74B 21M Sep/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026
Xencor USD 837M 278M Sep/2025